Possible Efficacy and Safety of Mebendazole in Patients With Ulcerative Colitis Treated With Mesalamine
NCT06335160 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 46
Last updated 2026-02-06
Summary
To evaluate the possible efficacy and safety of mebendazole in patients with ulcerative colitis treated with mesalamine
Conditions
Interventions
- DRUG
-
Mebendazole
mebendazole group, n = 23) which will receive the standard treatment for UC plus mebendazole 500 mg twice daily for 6 months
Sponsors & Collaborators
-
Tanta University
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-04-20
- Primary Completion
- 2026-04-30
- Completion
- 2026-05-31
Countries
- Egypt
Study Locations
More Related Trials
-
Schistosoma Mansoni Morbidity in Children Aged 1-5 Years
NCT01901484 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of Schistosomiasis Mansoni on HIV Susceptibility and Female Genital Immunology
NCT02878564 ·Status: COMPLETED ·Phase: PHASE4
-
Safety and Efficacy of Drug Combinations Against Schistosomiasis
NCT01050374 ·Status: COMPLETED ·Phase: NA
-
Schistosomiasis in Formal and Non-Formal Schools in Uganda: Implications for Control Programmes
NCT00463593 ·Status: COMPLETED
-
Study of Patients With Strongyloides Stercoralis Infection
NCT00001245 ·Status: COMPLETED
-
Monitoring Drug Efficacy and Anthelmintic Resistance in Soil-transmitted Helminth Programs
NCT04177654 ·Status: COMPLETED
-
Evaluation of Strategies for Improved Uptake of Preventive Treatment for Intestinal Schistosomiasis
NCT01869465 ·Status: UNKNOWN ·Phase: NA
-
Assessment of Combined Praziquantel and Albendazole vs Albendazole Alone to Treat Active Parenchymal Neurocysticercosis
NCT06376396 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Immunisation, Treatment and Controlled Human Hookworm Infection
NCT03702530 ·Status: COMPLETED ·Phase: NA
-
Schistosome and Intestinal Worm Infections and Malaria Morbidity Among School and Pre-school Children in, Tanzania
NCT00347113 ·Status: COMPLETED ·Phase: NA
-
The Effect of Praziquantel Treatment on Schistosoma Mansoni Morbidity and re-Infection Along Lake Victoria, Uganda
NCT00215267 ·Status: COMPLETED ·Phase: NA
-
Urogenital Schistosomiasis and Sexually Transmitted Infections in Madagascar
NCT00713999 ·Status: COMPLETED ·Phase: NA
-
Treatment of Female Genital Schistosomiasis (FGS) With Praziquantel: A Proof-of-Concept Study
NCT04115072 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Schistosoma Haematobium Infections and Praziquantel
NCT01558336 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of an AI-DP for STH Deworming Programs: a Study Protocol
NCT06055530 ·Status: UNKNOWN
-
The Chinese-made Praziquantel for Treatment of Schistosoma Haematobium
NCT03133832 ·Status: UNKNOWN ·Phase: PHASE3
-
Retrospective Study of Clinical Practice and Management of Imported Schistosomiasis in France
NCT04810741 ·Status: COMPLETED
-
Using Community-Based Volunteers to Reach Non-Enrolled School Aged Children Through Community-Directed Treatment of Schistosomiasis in School-Aged Children in Rural Northern Ghana
NCT00463931 ·Status: COMPLETED
-
Effect of Albendazole Dose on Clearance of Filarial Worms
NCT00339417 ·Status: COMPLETED ·Phase: PHASE2
-
Health Benefits of Repeated Treatment in Pediatric Schistosomiasis
NCT01424410 ·Status: COMPLETED
-
Parasitism & COVID19 Vaccines: New Challenge.
NCT05185778 ·Status: NOT_YET_RECRUITING
-
Repeated Controlled Human Schistosoma Mansoni Infection
NCT05085470 ·Status: COMPLETED ·Phase: NA
-
Strongyloidiasis at CHRU Nancy: Evaluation of the Performance of Serological Tests and Disease-associated Characteristics
NCT07296198 ·Status: COMPLETED
-
The Burden of (Neuro)Cysticercosis Among People Living With HIV in Rural Tanzania
NCT03851419 ·Status: COMPLETED
-
Epidemiology and Control of Mansonella Perstans Infection in Uganda
NCT00215280 ·Status: COMPLETED ·Phase: NA